Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,176 trials

NCT06562569
Recruiting
Non-invasive VNS for Parkinson's Gait
Not applicable · United States · 1 site
Registry update: 9 Jul 2026
NCT07105943
Recruiting
Manipulating Exercise Intensity and Affective Responses for Cardiac Rehabilitation Program Acute Coronary Syndrome Patients
Not applicable · Portugal · 2 sites
Registry update: 4 May 2026
NCT07477639
Recruiting
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Phase 1/2 · United States · 8 sites
Registry update: 21 Sept 2026
NCT07846462
Recruiting
Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
Not applicable · China · 1 site
Registry update: 1 Oct 2026
NCT07406139
Recruiting
PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）
Phase 4 · China · 1 site
Registry update: 12 Feb 2026
NCT07223814
Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Phase 3 · Austria, Australia, Belgium, Switzerland, Germany, Denmark, Estonia, Spain, Finland, Ireland, Italy, Japan, Lithuania, Netherlands, Norway, Poland, Sweden, United States · 175 sites
Registry update: 6 Nov 2026
NCT07417202
Recruiting
Intraoperative Wound Irrigation for Pilonidal Disease
Not applicable · United States · 1 site
Registry update: 26 May 2026
NCT07353671
Recruiting
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Phase 2/3 · China · 2 sites
Registry update: 25 Mar 2026
NCT07444060
Recruiting
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Not applicable · China · 1 site
Registry update: 2 Mar 2026
NCT07391813
Recruiting
SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer
Phase 1/2 · Serbia · 1 site
Registry update: 9 Mar 2026
NCT07506174
Recruiting
Pelvic PNF and Multiplanar Trunk Training in Stroke Patients
Not applicable · Pakistan · 1 site
Registry update: 9 Jun 2026
NCT07506109
Recruiting
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
Phase 2 · China · 4 sites
Registry update: 7 Apr 2026
NCT07351149
Recruiting
Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery
Not applicable · Australia, Brazil, Canada, Switzerland, France, Croatia, Italy, Netherlands, Serbia, Sweden · 16 sites
Registry update: 29 Sept 2026
NCT07491536
Recruiting
Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis
Not applicable · Italy · 1 site
Registry update: 24 Mar 2026
NCT07503652
Recruiting
Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
Phase 4 · China · 1 site
Registry update: 31 Mar 2026
NCT05029336
Recruiting
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
Phase 2 · United States · 1 site
Registry update: 14 Oct 2025
NCT07519603
Recruiting
Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program
Not applicable · Vietnam · 1 site
Registry update: 9 Apr 2026
NCT07469683
Recruiting
An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Phase 2 · South Korea · 1 site
Registry update: 13 Mar 2026
NCT07514897
Recruiting
Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Not applicable · China · 1 site
Registry update: 7 Apr 2026
NCT07570849
Recruiting
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma
Phase 2 · China · 1 site
Registry update: 6 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.